Skip to main content
SpringerLink
Log in

Pharmacological Agents Affecting Emesis

A Review (Part II)

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Part I of this article reviewed the pathophysiology of emesis, and its pharmacological treatment. Drug-induced vomiting was also discussed. In the second part of the review, other common causes of vomiting are considered.

The basis of the use of antiemetics in morning sickness and migraine is still obscure; for the latter, serotonin 5-HT1 receptor agonists, 5-HT3 receptor antagonists and dopamine D2 receptor antagonists are effective. For motion sickness, control can be achieved with various antagonists of muscarinic or histamine H1-receptors. Centrally active adrenoceptor agonists in combination with a muscarinic antagonist or H1-receptor antagonist may offer better control of motion sickness and its associated symptoms than either antagonist alone; based on clinical studies, post-operative vomiting after opiate administration appears to be controlled by blocking dopamine D2, histamine H1-or muscarinic receptors.

Radiation therapy appears to be similar to cytotoxic therapy in that the mediators produced or released by radiation activate both peripheral and central sites involved in the vomiting reflex. Blockade of dopamine D2 and 5-HT3 receptors may be effective.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aapro MS. 5-HT3 Receptor antagonists: an overview of their present status and future potential in cancer therapy-induced emesis. Drugs 42(4): 551–568, 1991

    CAS  PubMed  Google Scholar 

  • Abell TL, Malagelada J-R. Glucagon-evoked gastric dysrhythmias in humans shown by an improved electrogastrographic technique. Gastroenterology 88: 1932–1940, 1985

    CAS  PubMed  Google Scholar 

  • Abramowitz MD, Oh TH, Epstein BS, Ruttimann UE, Friendly DS. The antiemetic effect of droperidol following outpatient strabismus surgery in children. Anesthesiology 59: 579–583, 1983

    CAS  PubMed  Google Scholar 

  • ADRAC. Prescribing of antiemetics — is more caution necessary? Australian Adverse Drug Reactions Bulletin, March, Item 3, 1983

    Google Scholar 

  • ADRAC. Adverse reactions to Scop. Australian Adverse Drug Reactions Bulletin, March, Item 1, 1989

    Google Scholar 

  • Albertson TG, Derlet RW, Foulke GE, Minguillon MC, Tharratt SR. Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute toxic ingestions. Annals of Emergency Medicine 18: 56–59, 1989

    CAS  PubMed  Google Scholar 

  • Allan SG, Leonard RCF. Dexamethasone antiemesis and side effects. Lancet 1: 1035, 1986

    CAS  PubMed  Google Scholar 

  • Allan SG, Cornbleet MA, Warrington PS, Golland IM, Leonard RCF, et al. Dexamethasone and high dose metaclopramide: efficacy in controlling cisplatin induced nausea and vomiting. British Medical Journal 289: 878–879, 1984

    CAS  PubMed  Google Scholar 

  • Alphin RS, Proakis AG, Leonard CA, Smith WL, Dannenburg WN, et al. Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility. Digestive Diseases and Sciences 31: 524–529, 1986

    CAS  PubMed  Google Scholar 

  • American Medical Association Council on Pharmacy and Chemistry. Current status of therapy in nausea and vomiting of pregnancy. Journal of the American Medical Association 160: 208–209, 1956

    Google Scholar 

  • Amery WK, Waelkens J. Prevention of the last chance: an alternative pharmacologic treatment of migraine. Headache 23: 37–38, 1983

    CAS  PubMed  Google Scholar 

  • Amitai Y, Mitchell AA, McGuigan MA, Lovejoy Jr FH. Ipecac induced emesis and reduction of plasma concentrations of drugs following accidental overdosage in children. Pediatrics 80: 364–367, 1987

    CAS  PubMed  Google Scholar 

  • Amitai Y, Yeung AC, Moye J, Lovejoy Jr FH. Repetitive oral activated charcoal and control of emesis in severe theophylline toxicity. Annals of Internal Medicine 105: 386–387, 1986

    CAS  PubMed  Google Scholar 

  • Andrews PLR, Bailey HE, Hawthorn J, Stables R, Tyers MB. GR 38032F, a novel 5-HT3 receptor antagonist, can abolish emesis induced by cyclophosphamide or radiation in the ferret. British Journal of Pharmacology 91: 417P, 1987

    Google Scholar 

  • Andrews PLR, Davis CJ, Hawthorn J. Abdominal vagotomy modifies the emetic response to radiation in the ferret. Journal of Physiology 378: 16P, 1986

    Google Scholar 

  • Andrews PLR, Rapeport WG, Sanger GJ. Neuropharmacology of emesis induced by anti-cancer therapy. Trends in Pharmacological Sciences 9: 334–341, 1988

    CAS  PubMed  Google Scholar 

  • Archer CB, Amlot PL, Trounce JR. Antiemetic effect of nonabine in cancer chemotherapy: a double blind study comparing nonabine and chlorpromazine. British Medical Journal 286: 350–351, 1983

    CAS  PubMed  Google Scholar 

  • Assaf RAE, Clarke RSJ, Dundee JW, Samuel IO. Studies of drugs given before anaesthesia. XXIV. Metoclopramide with morphine and pethidine. British Journal of Anaesthesia 46: 514–519, 1974

    CAS  PubMed  Google Scholar 

  • Atlay RD, Weekes ARL. The treatment of gastrointestinal disease in pregnancy. Clinics in Obstetrics and Gynaecology 13: 335–347, 1986

    CAS  PubMed  Google Scholar 

  • Bailey PL, Streisand JB, Pace NL, Bubbers SJM, East KA, et al. Transdermal scopolamine reduces nausea and vomiting after outpatient laparoscopy. Anesthesiology 72: 977–980, 1990

    CAS  PubMed  Google Scholar 

  • Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In Goodman LS, et al. (Eds) The pharmacological basis of therapeutics, 7th ed., pp. 387–445, MacMillan, New York, 1985

    Google Scholar 

  • Barnes JM, Barnes NM, Costall B, Naylor RJ, Tattersall FD. Reserpine, parachlorophenylalanine and fenfluramine antagonise cisplatin-induced emesis in the ferret. Neuropharmacology 27: 783–790, 1988a

    CAS  PubMed  Google Scholar 

  • Barnes NM, Costall B, Ironside JW, Naylor RJ. Identification of 5-HT3 recognition sites in human brain tissue using [3H]zacopride. Journal of Pharmacy and Pharmacology 40: 668, 1988b

    CAS  PubMed  Google Scholar 

  • Barrett A. Total body irradiation (TBI) before bone marrow transplantation in leukaemia: a co-operative study from the European Group for Bone Marrow Transplantation. British Journal of Radiology 55: 562–567, 1982

    CAS  PubMed  Google Scholar 

  • Bateman DN, Kahn C, Legg NJ, Reid JL. Metoclopramide in Parkinson’s disease. Clinical Pharmacology and Therapeutics 24: 459–464, 1978

    CAS  PubMed  Google Scholar 

  • Bateman DN, Rawlins MD. Therapeutic potential of cannabinoids. British Medical Journal 284: 1211–1212, 1982

    CAS  PubMed  Google Scholar 

  • Bateman DN, Rawlins MD, Simpson JM. Extrapyramidal reactions with metoclopramide. British Medical Journal 291: 930–932, 1985

    CAS  PubMed  Google Scholar 

  • Bedikian AY, Valdivieso M, Heilbrun LK, Withers RH, Bodey GP, et al. Glycerol: an alternative to dexamethasone for patients receiving brain irradiation for metastatic disease. Southern Medical Journal 73: 1210–1214, 1980

    CAS  PubMed  Google Scholar 

  • Beleslin DB, Nedelkovski V. Emesis induced by 4(m-chlorophenylcarbamoyloxy)-2-butynyltrimethyl ammonium chloride (McN-A-343): evidence for a predominant central muscarinic M1 mediation. Neuropharmacology 27: 949–956, 1988

    CAS  PubMed  Google Scholar 

  • Bellville JW. Postanesthetic nausea and vomiting. Anesthesiology 22: 773–780, 1961

    CAS  PubMed  Google Scholar 

  • Bellville JW, Bross IDJ, Howland WS. Postoperative nausea and vomiting. IV. Factors related to postoperative nausea and vomiting. Anesthesiology 21: 186–193, 1960

    CAS  PubMed  Google Scholar 

  • Bennett JR, Stanciu C. The effect of metoclopramide on gastrooesophageal reflux. Postgraduate Medical Journal 49 (Suppl. 4): 65–68, 1973

    PubMed  Google Scholar 

  • Berger A, Schaumburg HH. More on neuropathy from pyridoxine abuse. New England Journal of Medicine 311: 986–987, 1984

    CAS  PubMed  Google Scholar 

  • Bermudez J, Boyle EA, Miner WD, Sanger GJ. The antiemetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694. British Journal of Cancer 58: 644–650, 1988

    CAS  PubMed  Google Scholar 

  • Bernier J, Huys J. The effect of domperidone on the symptomatic treatment of radiotherapy-induced nausea and vomiting. Postgraduate Medical Journal 55 (Suppl. 1): 52–53, 1979

    Google Scholar 

  • Bishop JF, Olver IN, Wolf MM, Matthews JP, Long M, et al. Lorazepam: a randomized, double blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine. Journal of Clinical Oncology 2: 691–695, 1984

    CAS  PubMed  Google Scholar 

  • Bishop JF, Wolf M, Matthews JP, Scott K, Ackland S, et al. Randomized, double blind, crossover study comparing prochlorperazine and lorazepam with high dose metoclopramide and lorazepam for control of emesis in patients receiving cytotoxic chemotherapy. Cancer Treatment Reports 71: 1007–1011, 1987

    CAS  PubMed  Google Scholar 

  • Blackwell CP, Harding SM. The clinical pharmacology of ondansetron. European Journal of Cancer and Clinical Oncology 25 (Suppl. 1): S21–S24, 1989

    Google Scholar 

  • Bluming AZ, Zeegen P. Cataracts induced by intermittent decadron used as an antiemetic. Journal of Clinical Oncology 4: 221–223, 1986

    CAS  PubMed  Google Scholar 

  • Boldy DAR, Buckley BM, Vale JA. Advances in the treatment of poisoning I. Journal of Clinical Hospital Pharmacy 9: 147–160, 1984

    CAS  Google Scholar 

  • Bonate PL. Serotonin receptor subtypes: functional, physiological, and clinical correlates. Clinical Neuropharmacy 14: 1–16, 1991

    CAS  Google Scholar 

  • Bonner Tl. New subtypes of muscarinic acetylcholine receptors. Trends in Pharmacological Sciences 10 (Suppl.): 11–15, 1989

    Google Scholar 

  • Borison HL. A misconception of motion sickness leads to false therapeutic expectations. Aviation Space and Environmental Medicine 56: 66–68, 1985

    CAS  Google Scholar 

  • Borison HL, Borison R. Motion sickness reflex arc bypasses the area postrema in cats. Experimental Neurology 92: 723–737, 1986

    CAS  PubMed  Google Scholar 

  • Borison HL, Borison R, McCarthy LE. Role of the area postrema in vomiting and related functions. Federation Proceedings 43: 2955–2957, 1984

    CAS  PubMed  Google Scholar 

  • Borison HL, Harris TD, Schmidt AM. Central emetic action of pilocarpine in the cat. Journal of Neuropathology and Experimental Neurology 15: 485–491, 1956

    CAS  PubMed  Google Scholar 

  • Borison HL, McCarthy LE. Neuropharmacology of chemotherapy-induced emesis. Drugs 25 (Suppl. 1): 8–17, 1983

    CAS  PubMed  Google Scholar 

  • Borison HL, Wang SC. Physiology and pharmacology of vomiting. Pharmacological Reviews 5: 193–230, 1953

    CAS  PubMed  Google Scholar 

  • Bormann J. Electrophysiology of GABAA and GABAB receptor subtypes. Trends in Neurosciences 11: 112–116, 1988

    CAS  PubMed  Google Scholar 

  • Boulanger M, Dubois A, Lecron L. Domperidone in the prevention of post-operative nausea and vomiting. Postgraduate Medical Journal 55 (Suppl.1): 45–47, 1979

    PubMed  Google Scholar 

  • Bowcock SJ, Stockdale AD, Bolton JAR, Kang AA, Retsas S. Antiemetic prophylaxis with high dose metoclopramide or lorazepam in vomiting induced by chemotherapy. British Medical Journal 288: 1879, 1984

    CAS  PubMed  Google Scholar 

  • Boyle EA, Miner WD, Sanger GJ. Different anti-cancer therapies evoke emesis by mechanisms that can be blocked by the 5-HT3 receptor antagonist BRL 43694. British Journal of Pharmacology 91: 418P, 1987

    Google Scholar 

  • Brand ED, Harris TD, Borison HL, Goodman LS. The antiemetic activity of 10-γ-dimethylaminopropyl)-2-chlorophenothiazine (chlorpromazine) in dog and cat. Journal of Pharmacology and Experimental Therapeutics 110: 86–92, 1954

    CAS  PubMed  Google Scholar 

  • Brand J. The pharmacologic basis for the control of motion sickness by drugs. Pharmacology for Physicians 2(3): 1–5, 1968

    CAS  PubMed  Google Scholar 

  • Brand JJ, Colquhoun WP, Gould AH, Perry WLM. Hyoscine and cyclizine as motion sickness remedies. British Journal of Pharmacology 30: 463–469, 1967

    CAS  Google Scholar 

  • Brand JJ, Colquhoun WP, Perry WLM. Side-effects of 1-hyoscine and cyclizine studied by objective tests. Aerospace Medicine 39: 999–1002, 1968

    CAS  PubMed  Google Scholar 

  • Brand JJ, Perry WLM. Drugs used in motion sickness. Pharmacological Reviews 18: 895–924, 1966

    CAS  PubMed  Google Scholar 

  • Brandes JM. First-trimester nausea and vomiting as related to outcome of pregnancy. Obstetrics and Gynecology 30: 427–431, 1967

    CAS  PubMed  Google Scholar 

  • Brizzee KR. Effect of localized brain stem lesions and supradiaphragmatic vagotomy on x-irradiation emesis in the monkey. American Journal of Physiology 187: 567–570, 1956

    CAS  PubMed  Google Scholar 

  • Brizzee KR, Mehler WR. The central nervous connections involved in the vomiting reflex. In Davis CJ, et al. (Eds) Nausea and vomiting: mechanisms and treatment pp. 31–55, Springer, Berlin, 1986

    Google Scholar 

  • Brizzee KR, Ordy JM, Mehler WR. Effect of ablation of area postrema on frequency and latency of motion sickness-induced emesis in the squirrel monkey. Physiology and Behaviour 24: 849–853, 1980

    CAS  Google Scholar 

  • Brock-Utne JG, Downing JW, Dimopoulos GE, Rubin J, Moshal MG. Effect of domperidone on lower esophageal sphincter tone in late pregnancy. Anesthesiology 52: 321–323, 1980

    CAS  PubMed  Google Scholar 

  • Brock-Utne JG, Rubin J, Welman S, Dimopoulos GE, Moshal MG, et al. The action of commonly used antiemetics on the lower oesophageal sphincter. British Journal of Anaesthesia 50: 295–298, 1978

    CAS  PubMed  Google Scholar 

  • Broekkamp CLE, Phillips AG, Cools AR. Stimulant effects of enkephalin microinjection into the dopaminergic A10 area. Nature 278: 560–562, 1979

    CAS  PubMed  Google Scholar 

  • Brown GW. Ondansetron: simplified dosing schedules. Ondansetron Satellite Symposium, Florence. Abstract, pp. 18–22, 1991

  • Bruera ED, Roca E, Cedaro L, Chacón R, Estévez R. Improved control of chemotherapy-induced emesis by the addition of dexamethasone to metoclopramide in patients resistant to metoclopramide. Cancer Treaments Reports 67: 381–383, 1983

    CAS  Google Scholar 

  • Bryson SM, McGovern EM, Kelman AW, White K, Addis GJ, et al. The pharmacokinetics of high dose metoclopramide in patients with neoplastic disease. British Journal of Clinical Pharmacology 19: 757–766, 1985

    CAS  PubMed  Google Scholar 

  • Buchheit K-H, Engel G, Mutschier E, Richardson B. Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum: evi-dence for two distinct release mechanisms. Naunyn-Schmiedebergs Archives of Pharmacology 329: 36–41, 1985

    CAS  Google Scholar 

  • Buckley BM, Braithwaite RA, Vale JA. Theophylline poisoning. Lancet 1: 618, 1983

    Google Scholar 

  • Buckley NJ, Bonner TI, Buckley CM, Brann MR. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Molecular Pharmacology 35: 469–476, 1989

    CAS  PubMed  Google Scholar 

  • Butler A, Hill JM, Ireland SJ, Jordan CC, Tyers MB. Pharmacological properties of GR 38032F, a novel antagonist at 5-HT3 receptors. British Journal of Pharmacology 94: 397–412, 1988

    CAS  PubMed  Google Scholar 

  • Carden PA, Mitchell SL, Waters KD, Tiedemann K, Ekert H. Prevention with cyclophosphamide/cytarabine-induced emesis with ondansetron in children with leukemia. Journal of Clinical Oncology 8: 1531–1535, 1990.

    CAS  PubMed  Google Scholar 

  • Carey MP, Burish TG. Etiology and treatment of the psychological side effects associated with cancer chemotherapy: a critical review and discussion. Psychological Bulletin 104: 307–325, 1988

    CAS  PubMed  Google Scholar 

  • Carlsson A, Lindqvist M. Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines. Journal of Pharmacy and Pharmacology 21: 460–464, 1969

    CAS  PubMed  Google Scholar 

  • Carmichael J, Cantwell BMJ, Edwards CM, Rapeport WG, Harris AL. The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin. British Medical Journal 297: 110–111, 1988

    CAS  PubMed  Google Scholar 

  • Carpenter DO. Neural mechanisms of emesis. Canadian Journal of Physiology and Pharmacology 68: 230–236, 1990

    CAS  PubMed  Google Scholar 

  • Carpenter DO, Briggs DB, Strominger N. Behavioural and electrophysiological studies of peptide-induced emesis in dogs. Federation Proceedings 43: 2952–2954, 1984

    CAS  PubMed  Google Scholar 

  • Carpenter DO, Briggs DB, Strominger NL. Mechanisms of radiation-induced emesis in the dog. Pharmacology and Therapeutics 39: 367–371, 1988

    CAS  PubMed  Google Scholar 

  • Carter RF, Fotheringham BJ. Fatal salt poisoning due to gastric lavage. Medical Journal of Australia 1: 539–541, 1971

    CAS  PubMed  Google Scholar 

  • Cassileth PA, Lusk EJ, Tom S, DiNubile N, Gerson SL. Anti-emetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy. Archives of Internal Medicine 143: 1347–1349, 1983

    CAS  PubMed  Google Scholar 

  • Champion MC. Domperidone. General Pharmacoloy 19: 499–505, 1988

    CAS  Google Scholar 

  • Chang AE, Shiling DJ, Stillman RC, Goldberg NH, Seipp CA, et al. Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate: a prospective randomised evaluation. Annals of Internal Medicine 91: 819–824, 1979

    CAS  PubMed  Google Scholar 

  • Chesselet MF, Chéramy A, Reisine TD, Glowinski J. Morphine and δ-opiate agonists locally stimulate in vivo dopamine release in the cat caudate nucleus. Nature 291: 320–322, 1981

    CAS  PubMed  Google Scholar 

  • Cheung BSK, Money KE, Jacobs I. Motion sickness susceptibility and aerobic fitness: a longitudinal study. Aviation Space and Environmental Medicine 61: 201–204, 1990

    CAS  Google Scholar 

  • Child CS. Prevention of neostigmine-induced colonic activity: a comparison of atropine and glycopyrronium. Anaesthesia 39: 1083–1085, 1984

    CAS  PubMed  Google Scholar 

  • Chinn HI, Bayne Jones S, Gersoni CS, Henderson AC, Zeransky HE, et al. Evaluation of drugs for protection against motion sickness aboard transport ships. Journal of the American Medical Association 160: 755–760, 1956

    Google Scholar 

  • Chinn HI, Noell WK, Smith PK. Prophylaxis of motion sickness. Archives of Internal Medicine 86: 810–822, 1950a

    CAS  PubMed  Google Scholar 

  • Chinn HI, Smith PK. Motion sickness. Pharmacological Reviews 7: 33–82, 1955

    CAS  PubMed  Google Scholar 

  • Chinn HI, Strickland BA, Oberst FW, Wilks SS, Tinkham M. Evaluation of some drugs in motion sickness. Journal of Aviation Medicine 21: 424–429, 1950b

    CAS  PubMed  Google Scholar 

  • Chu FCH, Paulshock M, Wallenstein SL, Houde RW, Phillips R. A controlled clinical study of metopimazine and perphenazine in treatment of radiation nausea and vomiting. Clinical Pharmacology and Therapeutics 10: 800–809, 1969

    CAS  PubMed  Google Scholar 

  • Clark MSG, Hatcher J, Brown F. Relative aversive potency of muscarinic agonists. Trends in Pharmacological Science 10 (Suppl.): 100, 1989a

    Google Scholar 

  • Clarke DE, Craig DA, Fozard JR. The 5-HT4 receptor: naughty, but nice. Trends in Pharmacological Sciences 10: 385–386, 1989b

    CAS  PubMed  Google Scholar 

  • Clarke RSJ. Nausea and vomiting. British Journal of Anaesthesia 56: 19–27, 1984

    CAS  PubMed  Google Scholar 

  • Clarke RSJ, Dundee JW, Loan WB. The use of post-operative vomiting as a means of evaluating anti-emetics. British Journal of Pharmacology 40: 568P–569P, 1970

    CAS  PubMed  Google Scholar 

  • Clissold SP, Heel RC. Transdermal hyoscine (scopolamine): a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 29(3): 189–207, 1985

    CAS  PubMed  Google Scholar 

  • Cookson RF. Mechanisms and treatment of post-operative nausea and vomiting. In Davis CJ, et al. (Eds) Nausea and vomiting: mechanisms and treatment, pp. 130–150, Springer, Berlin, 1986

    Google Scholar 

  • Cooper SM, McClelland CM, McRitchie B, Turner DH. BRL 24924: a new and potent gastric motility stimulant. British Journal of Pharmacology 88: 383P, 1986

    Google Scholar 

  • Cooper SM, McRitchie B. Role of dopamine and α-adrenoceptors in the control of gastric emptying in the rat: Possible involvement in the mechanism of action of metoclopromide. Journal of Autonomic Pharmacology 5: 325–331, 1985

    CAS  PubMed  Google Scholar 

  • Coper L. Using ipecac syrup. Australian Pharmacist 5: 28–29, 1986

    Google Scholar 

  • Corcoran M, Fox R, Brizzee K, Crampton G, Daunton N. Area postrema ablations in cats: evidence for separate neural routes for motion- and xylazine-induced CTA and emesis. Physiol-ogist 28: 330, 1985

    Google Scholar 

  • Cortés R, Probst A, Tobler H-J, Palacios JM. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies. Brain Research 362: 239–253, 1986

    PubMed  Google Scholar 

  • Costall B, Domeney AM, Gunning SJ, Kelly ME, Naylor RJ, et al. The action of dazopride to enhance gastric emptying and block emesis. Neuropharmacology 26: 669–677, 1987a

    CAS  PubMed  Google Scholar 

  • Costall B, Domeney AM, Gunning SJ, Naylor RJ, Tattersall FD, et al. GR 38032F: a potent and novel inhibitor of cisplatin-induced emesis in the ferret. British Journal of Pharmacology 90: 90P, 1987b

    Google Scholar 

  • Costall B, Gunning SJ, Naylor RJ. An analysis of the hypothalamic sites at which substituted benzamide drugs act to facilitate gastric emptying in the guinea-pig. Neuropharmacology 24: 869–875, 1985

    CAS  PubMed  Google Scholar 

  • Craig JB, Powell BL, White DR, Capizzi RL. Antiemetic therapy in patients treated with high-dose cytosine arabinoside. Oncology 44: 90–92, 1987

    CAS  PubMed  Google Scholar 

  • Cronin CM, Sallan SE, Gelber R, Lucas VS, Laszlo J. Antiemetic effect of intramuscular levonantradol in patients receiving anticancer chemotherapy. Journal of Clinical Pharmacology 21: 43S–50S, 1981

    CAS  PubMed  Google Scholar 

  • Crookewit S. The efficacy of ondansetron in emesis induced by total body irradiation. ZOFRAN (Ondansetron) Satellite Symposium, Copenhagen, Abstract, pp. 15–17, 1990

  • Crunden AB, Davis WA. The oral use of a phosphorated carbohydrate solution in nausea and vomiting of pregnancy. American Journal of Obstetrics and Gynecology 65: 311–313, 1953

    PubMed  Google Scholar 

  • Cubeddu LX, Hoffmann IS, Fuenmayor NT, Finn AL. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. New England Journal of Medicine 322: 810–816, 1990a

    CAS  PubMed  Google Scholar 

  • Cubeddu LX, Lindley CM, Wetsel W, Carl PL, Negro-Vilar A. Role of angiotensin II and vasopressin in cisplatin-induced emesis. Life Sciences 46: 699–705, 1990b

    CAS  PubMed  Google Scholar 

  • Cunningham D, Hawthorn J, Popie A, Gazet J-C, Ford HT, et al. Prevention of emesis in patients receiving cytotoxic drugs by GR 38032F, a selective 5-HT3 receptor antagonist. Lancet 1: 1461–1463, 1987

    CAS  PubMed  Google Scholar 

  • Cunningham D, Turner A, Hawthorn J, Rosin RD. Ondansetron with and without dexamethasone to treat chemotherapy induced emesis. Lancet 1: 1323, 1989

    CAS  PubMed  Google Scholar 

  • Danel V, Henry JA, Gluksman E. Activated charcoal, emesis, and gastric lavage in aspirin overdosage. British Medical Journal 296: 1507, 1988

    CAS  PubMed  Google Scholar 

  • Datta S, Alper MH, Ostheimer GW, Weiss JB. Method of ephedrine administration and nausea and hypotension during spinal anaesthesia for cesarean section. Anesthesiology 56: 68–70, 1982

    CAS  PubMed  Google Scholar 

  • Davies B, Andrewes D, Stargatt R, Ames D, Tuckwell Y, et al. Tacrine in Alzheimer’s Disease. Lancet 2: 163–164, 1989

    CAS  PubMed  Google Scholar 

  • Dennis T, Dubois A, Benavides J, Scatton B. Distribution of central ω1 (benzodiazepine1) and ω2 (benzodiazepine2) receptor subtypes in the monkey and human brain: an autoradiographic study with [3H]flunitrazepam and the ω1 selective ligand [3H]zolpidem. Journal of Pharmacology and Experimental Therapeutics 247: 309–322, 1988

    CAS  PubMed  Google Scholar 

  • Desmond PV, Watson KJR. Metoclopramide: a review. Medical Journal of Australia 144: 366–369, 1986

    CAS  PubMed  Google Scholar 

  • Diamond S, Freitag FG. Do non-steroidal anti-inflammatory agents have a role in the treatment of migraine headaches. Drugs 37: 755–760, 1989

    CAS  PubMed  Google Scholar 

  • Di Chiara G, Gessa GL. Pharmacology and neurochemistry of apomorphine. Advances in Pharmacology and Chemotherapy 15: 87–160, 1978

    PubMed  Google Scholar 

  • Dodds L. Cancer chemotherapy-induced nausea and vomiting. Pharmaceutical Journal 236: 588–590, 1986

    Google Scholar 

  • Dodds L. Treatment of “on-off” effects. Pharmaceutical Journal 241: 780, 1988

    Google Scholar 

  • Doig RK, Wolf S, Wolff HG. Study of gastric function in a “decorticate” man with gastric fistula. Gastroenterology 23: 40–44, 1953

    CAS  PubMed  Google Scholar 

  • Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E, et al. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. Journal of Pharmacology and Experimental Therapeutics 256: 727–733, 1991

    PubMed  Google Scholar 

  • Dubois A, Jacobus JP, Grissom MP, Eng RR, Conklin JJ. Altered gastric emptying and prevention of radiation-induced vomiting in dogs. Gastroenterology 86: 444–448, 1984

    CAS  PubMed  Google Scholar 

  • Dumont M, Bourbon P. Traitement des vomissements de la grossesse par la vitamine B6. Gynécologie et Obstetrique 49: 199–203, 1950

    CAS  PubMed  Google Scholar 

  • Dundee JW, Assaf RAE, Loan WB, Morrison JD. A comparison of the efficacy of cyclizine and perphenzine in reducing the emetic effects of morphine and pethidine. British Journal of Clinical Pharmacology 2: 81–85, 1975

    CAS  PubMed  Google Scholar 

  • Dundee JW, Clarke RSJ. The premedicant and anti-emetic action of metoclopramide. Postgraduate Medical Journal 49 (Suppl. 4): 34–37, 1973

    PubMed  Google Scholar 

  • Dundee JW, Moore J, Clarke RSJ. Studies of drugs given before anaesthesia. V. Pethidine 100mg alone and with atropine or hyoscine. British Journal of Anaesthesia 36: 703–710, 1964

    CAS  PubMed  Google Scholar 

  • Editorial. Emetics for acute poisoning: treatment or hazard? British Medical Journal 2: 977, 1977

  • Editorial. Antiemetics and cytotoxic drugs. Pharmaceutical Journal 233: 59–60, 1984

  • Editorial. Nausea and vomiting after general anaesthesia. Lancet 1: 651–652, 1989

  • Eggleston C, Hatcher RA. The seat of the emetic action of various drugs. Journal of Pharmacology and Experimental Therapeutics 7: 225–253, 1915

    CAS  Google Scholar 

  • Elias E, Gibson GJ, Greenwood LF, Hunt JN, Tripp JH. The slowing of gastric emptying by monosaccharides and disaccharides in test meals. Journal of Physiology 194: 317–326, 1968

    CAS  PubMed  Google Scholar 

  • Ellis FR, Spence AA. Clinical trials of metoclopramide (Maxolon) as an antiemetic in anaesthesia. Anaesthesia 25: 368–371, 1970

    CAS  PubMed  Google Scholar 

  • Emanuel MB. Specific calcium antagonists in the treatment of peripheral vascular disease. Angiology 30: 454–469, 1979

    CAS  PubMed  Google Scholar 

  • Eversmann TM, Gottsmann M, Uhlich E, Ulbrecht G, von Werder K, et al. Increased secretion of growth hormone prolactin, antidiuretic hormone and cortisol induced by the stress of motion sickness. Aviation Space and Environmental Medicine 49: 53–57, 1978

    CAS  Google Scholar 

  • Fair R. Ondansetron in nausea. Pharmaceutical Journal 245: 514, 1990

    Google Scholar 

  • Fairweather DVI. Nausea and vomiting in pregnancy. American Journal of Obstetrics and Gynecology 102: 135–175, 1968

    CAS  PubMed  Google Scholar 

  • Fairweather DVI. Mechanisms and treatment of nausea and vomiting in pregancy. In Davis CJ, et al. (Eds) Nausea and vomiting: mechanisms and treatment, pp. 151–159, Springer, Berlin, 1986

    Google Scholar 

  • Feigenbaum JJ, Richmond SA, Weissman Y, Mechoulam R. Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid. European Journal of Pharmacology 169: 159–165, 1989

    CAS  PubMed  Google Scholar 

  • Finney R. “Nidoxital”: a clinical trial. Clinical Radiology 12: 229–231, 1961

    CAS  PubMed  Google Scholar 

  • Fiumara AM, Henderson AM, Kearsley JA. Antiemetic premedicants in cisplatin-induced emesis. Australian Journal of Hospital Pharmacy 18: 84, 1988

    Google Scholar 

  • Fozard JR. 5-HT3 receptors and cytotoxic drug-induced vomiting. Trends in Pharmacological Sciences 8: 44–45, 1987

    CAS  Google Scholar 

  • Fragen RJ, Caldwell N. A new benzimidazole antiemetic, domperidone, for the treatment of postoperative nausea and vomiting. Anesthesiology 49: 289–290, 1978

    CAS  PubMed  Google Scholar 

  • Frauenfelder FT. Transdermal scopolamine precipitating narrow-angle glaucoma. New England Journal of Medicine 307: 1079, 1982

    Google Scholar 

  • Frytak S, Moertal CG, O’Fallon JR, Rubin J, Creagan ET, et al. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. Annals of Internal Medicine 91: 825–830, 1979

    CAS  PubMed  Google Scholar 

  • Gagen M, Gochnour D, Young D, Gaginella T, Neidhart J. A randomized trial of metoclopramide and a combination of dexamethasone and lorazepam for prevention of chemotherapy-induced vomiting. Journal of Clinical Oncology 2: 696–701, 1984

    CAS  PubMed  Google Scholar 

  • Gejrot T. Intravenous xylocaine in the treatment of attacks of Ménière’s diease. Acta Oto-Laryngologica 82: 301–302, 1976

    CAS  PubMed  Google Scholar 

  • Gejrot T. Intravenous xylocaine in the treatment of attacks of Ménière’s disease. Acta Oto-Laryngologica (Suppl. 188): 190–195, 1963

    Google Scholar 

  • Gerstner HB. Reactions to short-term radiation in man. Annual Review of Medicine 11: 289–302, 1960

    CAS  PubMed  Google Scholar 

  • Giraldo E, Hammer R, Ladinsky H. Distribution of muscarinic receptor subtypes in rat brain as determined in binding studies with AF-DX 116 and pirenzepine. Life Sciences 40: 833–840, 1987

    CAS  PubMed  Google Scholar 

  • Glaviano VV, Wang SC. Dual mechanisms of anti-emetic action of 10(γ-dimethylaminopropyl)-2-chlorophenothiazine hydrochloride (chlorpromazine) in dogs. Journal of Pharmacology and Experimental Therapeutics 114: 358–366, 1955

    CAS  PubMed  Google Scholar 

  • Goldberg LI, Volkman PH, Kohli JD. A comparison of the vascular dopamine receptor with other dopamine receptors. Annual Review of Pharmacology and Toxicology 18: 57–79, 1978

    CAS  PubMed  Google Scholar 

  • Gordon CR, Ben-Aryeh H, Szargel R, Attias J, Rolnick A, et al. Salivary changes associated with seasickness. Journal of the Autonomic Nervous System 26: 37–42, 1989

    CAS  PubMed  Google Scholar 

  • Goyal RK. Muscarinic receptor subtypes: physiology and clinical implications. New England Journal of Medicine 321: 1022–1029, 1989

    CAS  PubMed  Google Scholar 

  • Gralla RJ. Metoclopramide: a review of antiemetic trials. Drugs 25 (Suppl. 1): 63–73, 1983

    PubMed  Google Scholar 

  • Gralla RJ, Itri LM, Pisko SE, Squillante AE, Kelsen DP, et al. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. New England Journal of Medicine 305: 905–909, 1981

    CAS  PubMed  Google Scholar 

  • Gralla EJ, Sabod JP, Hayden DW, Yochmowitz MG, Mattsson JL. The effect of selected drugs on first-stage radioemesis in beagle dogs. Radiation Research 78: 286–295, 1979

    CAS  PubMed  Google Scholar 

  • Gralla RJ, Tyson LB, Clark RA, Bordin LA, Kelsen DP, et al. Antiemetic trials with high dose metoclopramide: superiority over THC, and preservation of efficacy in subsequent chemotherapy courses. Proceedings of the American Society of Clinical Oncologists 1: 58, 1982

    Google Scholar 

  • Graybiel A. Space motion sickness: Skylab revisited. Aviation Space and Environmental Medicine 51: 814–822, 1980

    CAS  Google Scholar 

  • Graybiel A, Knepton J. Sopite syndrome: a sometimes sole manifestation of motion sickness.. Aviation Space and Environmental Medicine 47: 873–882, 1976

    CAS  Google Scholar 

  • Grigoriev AI, Nichiporuk IA, Yasnetsov VV, Shashkov VS. Hormonal status and fluid electrolyte metabolism in motion sickness. Aviation Space and Environmental Medicine 59: 301–305, 1988

    CAS  Google Scholar 

  • Grossman B, Lessin LS, Cohen P. Droperidol prevents nausea and vomiting from cis-platinum. New England Journal of Medicine 301: 47, 1979

    CAS  PubMed  Google Scholar 

  • Gunning SJ, Bradbury AJ, Costall B, Naylor RJ. Evidence that 5-hydroxytryptamine may exert both facilitatory and inhibitory control of electrical field stimulation-evoked contractions in longitudinal muscle taken from the body of guinea pig stomach. Journal of Pharmacy and Pharmacology 38: 182–187, 1986

    CAS  PubMed  Google Scholar 

  • Gunning SJ, Hagan RM, Tyers MB. Cisplatin induces biochemical and histological changes in the small intestine of the ferret. British Journal of Pharmacy 90: 135P, 1987

    Google Scholar 

  • Gylys JA, Wright RN, Nicolosi WD, Buyniski JP, Crenshaw RR. BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties. Journal of Pharmacology and Experimental Therapeutics 244: 830–837, 1988

    CAS  PubMed  Google Scholar 

  • Hakkarainen H, Allonen H. Ergotamine vs metoclopramide vs their combination in acute migraine attacks. Headache 22: 10–12, 1982

    CAS  PubMed  Google Scholar 

  • Hakkarainen H, Vapaatalo H, Gothoni G, Parantainen J. Tolfenamic acid is as effective as ergotamine during migraine attacks. Lancet 2: 326–327, 1979

    CAS  PubMed  Google Scholar 

  • Hall ST, Ceuppens PR. A study to evaluate the effect of ondansetron on psychomotor performance after repeated oral dosing in healthy subjects. Psychopharmacologia 104: 86–90, 1991

    CAS  Google Scholar 

  • Hampson JP. The theophylline “therapeutic window” — fact or fallacy. Pharmaceutical Journal 241: 722–724, 1988

    Google Scholar 

  • Handford SW, Cove Jr TG, Chinn HI, Smith PK. Drugs preventing motion sickness at sea. Journal of Pharmacology and Experimental Therapeutics 111: 447–453, 1954

    CAS  PubMed  Google Scholar 

  • Hanson WR, Houseman KA, Collins PW. Radiation protection in vivo by prostaglandins and related compounds of the arachidonic acid cascade. Pharmacology and Therapeutics 39: 347–356, 1988

    CAS  PubMed  Google Scholar 

  • Harding RK. Prodromal effects of radiation: pathways, models, and protection by antiemetics. Pharmacology and Therapeutics 39: 335–345, 1988

    CAS  PubMed  Google Scholar 

  • Harding RK, Hugenholtz H, Keaney M, Kucharczyk J. Discrete lesions of the area postrema abolish radiation-induced emesis in the dog. Neuroscience Letters 53: 95–100, 1985

    CAS  PubMed  Google Scholar 

  • Hargreaves J. A double blind placebo controlled study of cinnarizine in the prophylaxis of seasickness. Practitioner 224: 547–550, 1980

    CAS  PubMed  Google Scholar 

  • Hargreaves J. The prophylaxis of seasickness: a comparison of cinnarizine with hyoscine. Practitioner 226: 160, 1982

    CAS  PubMed  Google Scholar 

  • Harrington RA, Hamilton CW, Brogden RN, Linkewich JA, Romankiewicz JA, et al. Metoclopramide: an updated review of its pharmacological properties and clinical use. Drugs 25: 451–494, 1983

    CAS  PubMed  Google Scholar 

  • Harris AL. Cytotoxic-therapy-induced vomiting is mediated via enkephalin pathways. Lancet 1: 714–716, 1982

    CAS  PubMed  Google Scholar 

  • Harris AL, Cantwell BMJ. Mechanisms and treatment of cytotoxic-induced nausea and vomiting. In Davis CJ, et al. (Eds) Nausea and vomiting: mechanisms and treatment, pp. 78–93, Springer, Berlin, 1986

    Google Scholar 

  • Hawthorn J, Ostler KJ, Andrews PLR. The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret. Quarterly Journal of Experimental Physiology 73: 7–21, 1988

    CAS  PubMed  Google Scholar 

  • Hay AM, Man WK. Effect of metoclopramide on guinea pig stomach. Gastroenterology 76: 492–496, 1979

    CAS  PubMed  Google Scholar 

  • Henderson IWD. Congenital deformities associated with Bendectin. Canadian Medical Association Journal 117: 721–722, 1977

    CAS  PubMed  Google Scholar 

  • Henderson WR, Wilson WC. Intraventricular injection of acetyl-choline and eserine in man. Quarterly Journal of Experimental Physiology 26: 83–95, 1937

    Google Scholar 

  • Herman TS, Lawrence HE, Jones SE, Nagy C, Chester AB, et al. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. New England Jour-nal of Medicine 300: 1295–1297, 1979

    CAS  Google Scholar 

  • Herxheimer A. Treatment of morning sickness. Drug and Therapeutics Bulletin 6: 41–43, 1968

    Google Scholar 

  • Herxheimer A. Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy. Drug and Therapeutics Bulletin 22: 9–11, 1984

    Google Scholar 

  • Hesseltine HC. Pyridoxine failure in nausea and vomiting of pregnancy. American Journal of Obstetrics and Gynecology 51: 82–86, 1946

    CAS  PubMed  Google Scholar 

  • Higgins GA, Kilpatrick GJ, Bunce KT, Jones BJ, Tyers MB. 5HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. British Journal of Pharmacology 97: 247–255, 1989

    CAS  PubMed  Google Scholar 

  • Holling HE, McArdle B, Trotter WR. Prevention of seasickness by drugs. Lancet 1: 127–129, 1944

    Google Scholar 

  • Homick JL, Kohl RL, Reschke MF, Degioanni J, Cintron-Trevino NM. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy. Aviation Space and Environmental Medicine 54: 994–1000, 1983

    CAS  Google Scholar 

  • Hoss W, Ellis J. Muscarinic receptor subtypes in the central nervous system. International Review of Neurobiology 26: 151–199, 1985

    CAS  PubMed  Google Scholar 

  • Housley GD, Norris CH, Guth PS. Histamine and related substances influence neurotransmission in the semicircular canal. Hearing Research 35: 87–98, 1988

    CAS  PubMed  Google Scholar 

  • Hunt JN, Knox MT. The slowing of gastric emptying by nine acids. Journal of Physiology 201: 161–179, 1969

    CAS  PubMed  Google Scholar 

  • Hurst JA, Dozzi AM. The emergency treatment of poisoning in children. Medical Journal of Australia 2: 432–438, 1975

    CAS  PubMed  Google Scholar 

  • Ignoffo R. Oncology. In Katcher BS, et al. (Eds) Applied therapeutics: the clinical use of drugs, 3rd ed., pp. 899–941, Applied Therapeutics Inc., San Francisco, 1983

    Google Scholar 

  • Ilett KF, Gibb SM, Unsworth RW. Syrup of ipecacuanha as an emetic in adults. Medical Journal of Australia 2: 91–93, 1977

    CAS  PubMed  Google Scholar 

  • Ireland SJ, Tyers MB. Pharmacological characterization of 5-hy-droxytryptamine-induced depolarization of the rat isolated vagus nerve. British Journal of Pharmacology 90: 229–238, 1987

    CAS  PubMed  Google Scholar 

  • Irvine MKA. Drugs and dopamine. Pharmaceutical Journal 239: 262–264, 1987

    Google Scholar 

  • Isaacs B, Macarthur JG. Influence of chlorpromazine and promethazine on vomiting induced with apomorphine in man. Lancet 2: 570–572, 1954

    Google Scholar 

  • Jackson RT, Turner JS. Astemizole: its use in the treatment of patients with chronic vertigo. Archives of Otolaryngology — Head and Neck Surgery 113: 536–542, 1987

    CAS  PubMed  Google Scholar 

  • Jacobs AJ, Deppe G, Cohen CJ. A comparison of the antiemetic effects of droperidol and prochlorperazine in chemotherapy with cis-platinum. Gynecologic Oncology 10: 55–57, 1980

    CAS  PubMed  Google Scholar 

  • Jaffe JA, Martin WR. Opioid analgesics and antagonists. In Goodman LS, et al. (Eds) The pharmacological basis of therapeutics, 5th ed., pp. 245–283, MacMillan, New York, 1975

    Google Scholar 

  • Jaju BP, Wang SC. Effects of diphenhydramine and dimenhy-drinate on vestibular neuronal activity of cat: search for the locus of their antimotion sickness action. Journal of Pharmacology and Experimental Therapeutics 176: 718–724, 1971

    CAS  PubMed  Google Scholar 

  • Jarvik ME. Necessary risks. New England Journal of Medicine 300: 1330, 1979

    CAS  PubMed  Google Scholar 

  • Johnson BF, O’Grady J, Bye C. The influence of digoxin particle size on absorption of digoxin and the effect of propantheline and metoclopramide. British Journal of Clinical Pharmacology 5: 465–467, 1978

    CAS  PubMed  Google Scholar 

  • Jones AL, Hill AS, Soukop M, Hutcheon AW, Cassidy J, et al. Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet 338: 483–487, 1991

    CAS  PubMed  Google Scholar 

  • Jones O, Smyth N. The use of syrup of ipecacuanha as a first-aid measure in the management of accidental poisoning in the home. Australian Journal of Pharmacy 56: 607–608, 1975

    Google Scholar 

  • Joss RA, Goldhirsch A, Brunner KW, Galeazzi RL. Sudden death in cancer patient on high-dose domperidone. Lancet 1: 1019, 1982

    CAS  PubMed  Google Scholar 

  • Kalia M, Mesulam M-M. Brain stem projections of sensory and motor components of the vagus complex in the cat. I. The cervical vagus and nodose ganglion. Journal of Comparative Neurology 193: 435–465, 1980a

    CAS  PubMed  Google Scholar 

  • Kalia M, Mesulam M-M. Brain stem projections of sensory and motor components of the vagus complex in the cat. II. Laryngeal, tracheobronchial, pulmonary, cardiac and gastrointestinal branches. Journal of Comparative Neurology 193: 467–508, 1980b

    CAS  PubMed  Google Scholar 

  • Kato E, Narahashi T. Characteristics of the electrical response to dopamine in neuroblastoma cells. Journal of Physiology 333: 213–226, 1982

    CAS  PubMed  Google Scholar 

  • Kauppila A, Heikinheimo M, Lohela H, Ylikorkala O. Human chorionic gonadotrophin and pregnancy-specific beta-1-glyco-protein in predicting pregnancy outcome and in association with early pregnancy vomiting. Gynecologic and Obstetric Investigation 18: 49–53, 1984

    CAS  PubMed  Google Scholar 

  • Kauppila A, Huhtaniemi I, Ylikorkala O. Raised serum human chorionic gonadotrophin concentrations in hyperemesis gravidarium. British Medical Journal 1: 1670–1671, 1979

    CAS  PubMed  Google Scholar 

  • Kauppila A, Ylikorkala O, Järvinen PA, Haapalahti J. The function of the anterior pituitary-adrenal cortex axis in hyperemesis gravidarium. British Journal of Obstetrics and Gynaecology 83: 11–16, 1976

    CAS  PubMed  Google Scholar 

  • Kearsley JH, Dickman J, Sims K, Coates A, Fox RM, et al. Singleagent versus combination antiemetic treatments in patients receiving cytotoxic chemotherapy. Medical Journal of Australia 2: 32–34, 1982

    CAS  PubMed  Google Scholar 

  • Keist BF, Sheeley WF, Byers JM, Chinn HI. Effect of head immobilization on incidence of airsickness. Journal of Applied Physiology 8: 369–370, 1956

    CAS  PubMed  Google Scholar 

  • Kilpatrick GJ, Bunce KT, Tyers MB. 5-HT3 receptors. Medicinal Research Reviews 10: 441–475, 1990

    CAS  PubMed  Google Scholar 

  • Kilpatrick GJ, Jones BJ, Tyers MB. Identification and distribution of 5HT3 receptors in rat brain using radioligand binding. Nature 330: 746–748, 1987

    CAS  PubMed  Google Scholar 

  • King MJ, Milazkiewicz R, Carli F, Deacock AR. Influence of neostigmine on postoperative vomiting. British Journal of Anaesthesia 61: 403–406, 1988

    CAS  PubMed  Google Scholar 

  • Knapp RB, Fierro L. Evaluation of the cardiopulmonary safety and effects of lorazepam as a premedicant. Anaesthesia and Analgesia 53: 122–124, 1974

    CAS  Google Scholar 

  • Kohl RL. Endocrine correlates of susceptibility to motion sickness. Aviation Space and Environmental Medicine 56: 1158–1165, 1985

    CAS  Google Scholar 

  • Kohl RL. Failure of metoclopramide to control emesis or nausea due to stressful angular or linear acceleration. Aviation Space and Environmental Medicine 58: 125–131, 1987

    CAS  Google Scholar 

  • Kohl RL, Calkins DS, Mandell AJ. Arousal and stability: The effect of five new sympathomimetic drugs suggest a new principle for the prevention of space motion sickness. Aviation Space and Environmental Medicine 57: 137–143, 1986

    CAS  Google Scholar 

  • Kohl RL, Homick JL, Cintron N, Calkins DS. Lack of effect of astemizole on vestibular ocular reflex, motion sickness and cognitive performance in man. Aviation Space and Environmental Medicine 58: 1171–1175, 1987

    CAS  Google Scholar 

  • Kohl RL, Lin KK, Johnson PP. Susceptibility to stressful motion correlates with drug and hormonal response. Clinical Pharmacology and Therapeutics 35: 251, 1984

    Google Scholar 

  • Korttila K, Kauste A, Auvinen J. Comparison of domperidone, droperidol and metoclopramide in the prevention and treatment of nausea and vomiting after balanced general anaesthesia. Anaesthesia and Analgesia 58: 396–400, 1979

    CAS  Google Scholar 

  • Koski EMJ, Mattila MAK, Knapik D, Toivanen T, Ruusukallio H, et al. Double blind trial comparison of transdermal hyoscine and placebo for the prevention of postoperative nausea. British Journal of Anaesthesia 64: 16–20, 1990

    CAS  PubMed  Google Scholar 

  • Kris MG, Gralla RJ, Clark RA, Tyson LB, Fiore JJ, et al. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone. Cancer Treatment Reports 69: 1257–1262, 1985a

    CAS  PubMed  Google Scholar 

  • Kris MG, Gralla RJ, Clark RA, Tyson LB, O’Connell JP, et al. Incidence, course, and severity of delayed nausea and vomiting following the administration of high dose cis-platin. Journal of Clinical Oncology 3: 1379–1384, 1985b

    CAS  PubMed  Google Scholar 

  • Kris MG, Gralla RJ, Tyson LB, Clark RA. Antiemetics and cytotoxic drugs. British Medical Journal 287: 363–364, 1983

    CAS  PubMed  Google Scholar 

  • Kris MG, Gralla RJ, Tyson LB, Clark RN, Kelsen DP, et al. Improved control of cisplatin-induced emesis with high dose metoclopramide and with combinations of metoclopramide, dexamethasone and diphenhydramine. Cancer 55: 527–534, 1985c

    CAS  PubMed  Google Scholar 

  • Kucharczyk J, Harding RK. Regulatory peptides and the onset of nausea and vomiting. Canadian Journal of Physiology and Pharmacology 68: 289–293, 1990

    CAS  PubMed  Google Scholar 

  • Kullander S, Kälten B. A prospective study of drugs and pregnancy II. Antiemetic drugs. Acta Obstetricia et Gynaecologica Scandinavica 55: 105–111, 1976

    CAS  Google Scholar 

  • Laduron PM, Leysen JE. Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity. Biochemical Pharmacology 28: 2161–2165, 1979

    CAS  PubMed  Google Scholar 

  • Lance JW. Mechanism and management of headache, 4th ed., Butterworths, London 1982

    Google Scholar 

  • Langdon N, Malcolm PN, Parkes JD. Comparison of levodopa with carbidopa and levodopa with domperidone in Parkinson’s disease. Clinical Neuropharmacology 9: 440–447, 1986

    CAS  PubMed  Google Scholar 

  • Lans HS, Gollin HA, Daro AF, Nova E. Hypokalemia due to persistent vomiting during pregnancy. Journal of the American Medical Association 153: 1012–1015, 1953

    CAS  PubMed  Google Scholar 

  • Laszlo J. Nausea and vomiting as major complications of cancer chemotherapy. Drugs 25 (Suppl.1); 1–7, 1983

    PubMed  Google Scholar 

  • Laszlo J, Clark RA, Hanson DC, Tyson L, Crumpler L, et al. Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic, and anxiolytic effects. Journal of Clinical Oncology 3: 864–869, 1985

    CAS  PubMed  Google Scholar 

  • Laszlo J, Gralla RJ, Einhorn LH, Wampler G. Antiemetics: a round table discussion. Drugs 25 (Suppl. 1): 74–80, 1983

    Google Scholar 

  • Laszlo J, Lucas VS, Hanson DC, Cronin CM, Sallan SE. Levonantradol for chemotherapy-induced emesis: phase I-II oral administration. Journal of Clinical Pharmacology 21: 51S–56S, 1981

    CAS  PubMed  Google Scholar 

  • Lathers CM, Charles JB, Bungo MW. Pharmacology in space. Part 2: Controlling motion sickness. Trends in Pharmacological Sciences 10: 243–250, 1989

    CAS  PubMed  Google Scholar 

  • Lazareno S, Buckley NF, Roberts FF. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells. Molecular Pharmacology 38: 805–815, 1990

    CAS  PubMed  Google Scholar 

  • Lee BJ. Methylprednisolone as an antiemetic. New England Journal of Medicine 304: 486, 1981

    CAS  PubMed  Google Scholar 

  • Leibundgut U, Lancranjan I. First results with ICS205-930 (5HT3 receptor antagonist) in prevention of chemotherapy-induced emesis. Lancet 1: 1198, 1987

    CAS  PubMed  Google Scholar 

  • Lemberger L. Cannabinoids: potential therapeutic utility. Trends in Pharmacological Science 1: 321–323, 1980

    CAS  Google Scholar 

  • Lerman J, Eustis S, Smith DR. Effect of droperidol pretreatment on postanesthetic vomiting in children undergoing strabismus surgery. Anesthesiology 65: 322–325, 1986

    CAS  PubMed  Google Scholar 

  • Leslie RA, Gwyn DG. Neuronal connections of the area postrema. Federation Proceedings 43: 2941–2943, 1984

    CAS  PubMed  Google Scholar 

  • Leslie RA, Murphy KM, Robertson HA. Nodose ganglionectomy selectively reduces muscarinic cholinergic and delta opioid binding sites in the dorsal vagal complex of the cat. Neuroscience 32: 481–492, 1989

    CAS  PubMed  Google Scholar 

  • Leslie RA, Shah Y, Thejomayen M, Murphy KM. The neuro-pharmacology of emesis: the role of receptors in the neuro-modulation of nausea and vomiting. Canadian Journal of Physiology and Pharmacology 68: 279–288, 1990

    CAS  PubMed  Google Scholar 

  • Lind B, Breivik H. Metoclopramide and perphenazine in the prevention of postoperative nausea and vomiting. British Journal of Anaesthesia 42: 614–617, 1970

    CAS  PubMed  Google Scholar 

  • Lindstrom PA, Brizzee KR. Relief of intractable vomiting from surgical lesions in the area postrema. Journal of Neurosurgery 19: 228–236, 1962

    CAS  PubMed  Google Scholar 

  • London SW, McCarthy LE, Borison HL. Suppression of cancer chemotherapy induced vomiting in the cat by nabilone, a synthetic cannabinoid. Proceedings of the Society for Experimental Biology and Medicine 160: 437–440, 1979

    CAS  PubMed  Google Scholar 

  • Lucas VS, Laszlo Jr J. Δ9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy. Journal of the American Medical Association 243: 1241–1243, 1980

    PubMed  Google Scholar 

  • Madej TH, Simpson KA. Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following gynaecological surgery in day cases. British Journal of Anaesthesia 58: 879–883, 1986a

    CAS  PubMed  Google Scholar 

  • Madej TH, Simpson KA. Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following major gynaecological surgery. British Journal of Anaesthesia 58: 884–887, 1986b

    CAS  PubMed  Google Scholar 

  • Maher J. Intravenous lorazepam to prevent nausea and vomiting associated with cancer chemotherapy. Lancet 1: 91–92, 1981

    CAS  PubMed  Google Scholar 

  • Manara AR, Shelly MP, Quinn K, Park GR. The effect of metoclopramide on the absorption of oral controlled release morphine. British Journal of Clinical Pharmacology 25: 518–521, 1988

    CAS  PubMed  Google Scholar 

  • Manninen V, Apajalahti A, Melin J, Karesoja M. Altered absorption of digoxin in patients given propantheline and metoclopramide. Lancet 1: 398–400, 1973

    CAS  PubMed  Google Scholar 

  • Marshall NW. A double blind trial of metoclopramide and prochlorperazine in general practice. British Journal of Clinical Practice 24: 25–27, 1970

    CAS  PubMed  Google Scholar 

  • Martin IL. The benzodiazepines and their receptors: 25 years of progress. Neuropharmacology 26: 957–970, 1987

    CAS  PubMed  Google Scholar 

  • Marty M. Ondansetron in the prophylaxis of acute cisplatin-induced nausea and vomiting. European Journal of Cancer and Clinical Oncology 25 (Suppl.1): S41–S45, 1989

    Google Scholar 

  • Marty M, Pouillart P, Scholl S, Droz JP, Azab M, et al. Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high dose metoclopramide in the control of cisplatin-induced emesis. New England Journal of Medicine 322: 816–821, 1990

    CAS  PubMed  Google Scholar 

  • Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner T. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561–564, 1990

    CAS  PubMed  Google Scholar 

  • Matsuoka O, Tsuchiya T, Furukawa Y. The effect of x-irradiation on 5-hydroxytryptamine (serotonin) contents in the small intestines of experimental animals. Journal of Radiation Re-search 3: 104–108, 1962

    CAS  Google Scholar 

  • Matts SGF. Metoclopramide in the treatment of migraine. Practitioner 212: 887–890, 1974

    CAS  PubMed  Google Scholar 

  • Mattsson JL, Cordts RE, Yochmovitz MG, Hardy KA. Prevention of radiation emesis in dogs by a combination of drugs. International Journal of Radiation Oncology Biology Physics 10: 1067–1072, 1984

    CAS  Google Scholar 

  • Maxfield JR, Mcllwain AJ, Robertson JE. Treatment of radiation sickness with vitamin B6 (pyridoxine hydrochloride). Radiology 41: 383–388, 1943

    Google Scholar 

  • McBride WG. An aetiological study of drug ingestion by women who gave birth to babies with cleft palate. Australian and New Zealand Journal of Obstetrics and Gynaecology 9: 103–104, 1969

    CAS  PubMed  Google Scholar 

  • McCarthy LE, Borison HL. Cisplatin-induced vomiting eliminated by ablation of the area postrema in cats. Cancer Treatment Reports 68: 401–404, 1984

    CAS  PubMed  Google Scholar 

  • McKinney M, Anderson D, Forray C, El-Fakahany EE. Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor. Journal of Pharmacology and Experimental Therapeutics 250: 565–572, 1989

    CAS  PubMed  Google Scholar 

  • McMurray GN. An evaluation of metoclopramide as an antiemetic in seasickness. Postgraduate Medical Journal 49 (Suppl. 4): 38–41, 1973

    PubMed  Google Scholar 

  • McRitchie B, McClelland CM, Cooper SM, Turner DH, Sanger GJ. Dopamine antagonists as anti-emetics and as stimulants of gastric motility. In Bennett A, Velo G (Eds) Mechanisms of gastrointestinal motility and secretion, pp. 287–301, Plenum Press, New York, 1984

    Google Scholar 

  • Medin S, Nyberg L. Effect of propantheline and metoclopramide on absorption of digoxin. Lancet 1: 1393, 1973

    CAS  PubMed  Google Scholar 

  • Melnick BM, Johnson LS. Effects of eliminating nitrous oxide in outpatient anesthesia. Anesthesiology 67: 982–984, 1987

    CAS  PubMed  Google Scholar 

  • Miller AD, Wilson VJ. Vomiting centre reanalysed: an electrical stimulation study. Brain Research 270: 154–158, 1983

    CAS  PubMed  Google Scholar 

  • Miller JD, Brizzee KR. The anti-emetic properties of L-sulpiride in a ground-based model of space motion sickness. Life Sciences 41: 1815–1822, 1987

    CAS  PubMed  Google Scholar 

  • Milne RJ, Heel RC. Ondansetron. Therapeutic use as an antiemetic. Drugs 41: 574–595, 1991

    CAS  PubMed  Google Scholar 

  • Miner WD, Sanger GH. Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. British Journal of Pharmacology 88: 497–499, 1986

    CAS  PubMed  Google Scholar 

  • Miner WD, Sanger GJ, Turner DH. Comparison of the effect of BRL 24924, metoclopramide and domperidone on cisplatin-induced emesis in the ferret. British Journal of Pharmacology 88: 374P, 1986

    Google Scholar 

  • Miner WD, Sanger GJ, Turner DH. Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis. British Journal of Cancer 56: 159–162, 1987

    CAS  PubMed  Google Scholar 

  • Mitchelson F. Muscarinic receptor differentiation. Pharmacology and Therapeutics 37: 357–423, 1988

    CAS  PubMed  Google Scholar 

  • Moertel CG, Reitemeier RJ. Controlled clinical studies of orally administered antiemetic drugs. Gastroenterology 57: 262–268, 1969

    CAS  PubMed  Google Scholar 

  • Moertel CG, Reitemeier RJ, Gage RP. A controlled clinical evaluation of antiemetic drugs. Journal of the American Medical Association 186: 116–118, 1963

    CAS  PubMed  Google Scholar 

  • Monkovic I, Willner D, Adam MA, Brown M, Crenshaw RR, et al. Substituted Benzamides. I. Potential non-dopaminergic antagonists of chemotherapy-induced nausea and emesis. Journal of Medicinal Chemistry 31: 1548–1558, 1988

    CAS  PubMed  Google Scholar 

  • Morran C, Smith DC, Anderson DA, McArdle CS. Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomized trial of antiemetics. British Medical Journal 1: 1323–1324, 1979

    CAS  PubMed  Google Scholar 

  • Morrow G. Clinical characteristics associated with the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment. Journal of Clinical Oncology 2: 1170–1176, 1984

    CAS  PubMed  Google Scholar 

  • Morrow G. The effect of susceptibility to motion sickness on the side effects of cancer chemotherapy. Cancer 55: 2766–2770, 1985

    CAS  PubMed  Google Scholar 

  • Morrow GR, Arseneau JC, Asbury RF, Bennett JM, Boros L. Anticipatory nausea and vomiting with chemotherapy. New England Journal of Medicine 306: 431–432, 1982

    CAS  PubMed  Google Scholar 

  • Morrow GR, Dobkin PL. Anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment: prevalence, etiology and behavioural interventions. Clinical Psychology Review 8: 517–556, 1988

    Google Scholar 

  • Mortensen PT. Droperidol (Dehydrobenzperidol®): postoperative anti-emetic effect when given intravenously to gynaecological patients. Acta Anaesthesiologica Scandinavica 26: 48–52, 1982

    CAS  PubMed  Google Scholar 

  • Mowrey DB, Clayson DE. Motion sickness, ginger, and psycho-physics. Lancet 1: 655–657, 1982

    CAS  PubMed  Google Scholar 

  • Moyer JH, Kinross-Wright V, Finney RM. Chlorpromazine as a therapeutic agent in clinical medicine. Archives of Internal Medicine 95: 202–218, 1955

    CAS  PubMed  Google Scholar 

  • Mughal TI. Improved tolerance of cytotoxic chemotherapy with lorazepam. Oncology 40: 392–394, 1983

    CAS  PubMed  Google Scholar 

  • Muir JJ, Warner MA, Offord KP, Buck CF, Harper JV, et al. Role of nitrous oxide and other factors in postoperative nausea and vomiting: a randomized and blinded prospective study. Anesthesiology 66: 513–518, 1987

    CAS  PubMed  Google Scholar 

  • Mutschler E, Moser U, Wess J, Lambrecht G. Muscarinic receptor subtypes: agonists and antagonists. In Van Zwieten PA & Schönbaum E (Eds) Progress in Pharmacology and Clinical Pharmacology, Vol. 7, pp. 13–31, Gustav Fischer, Stuttgart, 1989

    Google Scholar 

  • Neidhart JA, Gagen M, Young D, Wilson HE. Specific anti-emetics for specific chemotherapeutic agents: Haloperidol versus benzquinamide. Cancer 47: 1439–1443, 1981

    CAS  PubMed  Google Scholar 

  • Nerenz DR, Leventhal H, Easterling DV, Love RR. Anxiety and drug taste as predictors of anticipatory nausea in cancer chemotherapy. Journal of Clinical Oncology 4: 224–233, 1986

    CAS  PubMed  Google Scholar 

  • Nilvebrant L, Sparf B. Receptor binding profiles of some selective muscarinic receptor antagonists. European Journal of Pharmacology 151: 83–96, 1988

    CAS  PubMed  Google Scholar 

  • Norris CH, Jackson RT. Inhibition by astemizole of activity from the isolated semicircular canal. Archives of Otolaryngology — Head and Neck Surgery 113: 981–983, 1987

    CAS  PubMed  Google Scholar 

  • Norton S, Colville KI, Light AE, Wnuck AL, Fanelli RV, et al. Pharmacologic properties of cyclizine hydrochloride (Marezine). Journal of Pharmacology and Experimental Therapeutics 112: 297–305, 1954

    CAS  PubMed  Google Scholar 

  • Oman CM. Motion sickness: a synthesis and evaluation of the sensory conflict theory. Canadian Journal of Physiology and Pharmacology 68: 294–303, 1990

    CAS  PubMed  Google Scholar 

  • Oman CM, Lichtenberg BK, Money KE, McCoy RK. M.I.T./Ca-nadian vestibular experiments on the Spacelab-1 mission: 4. Space motion sickness: symptoms, stimuli and predictability. Experimental Brain Research 64: 316–334, 1986

    CAS  Google Scholar 

  • Orme MLE. The Debendox saga. British Medical Journal 291: 918–919, 1985

    CAS  PubMed  Google Scholar 

  • Palacios JM, Cortés R, Probst A, Karobath M. Mapping of subtypes of muscarinic receptors in the human brain with receptor autoradiographic techniques. Trends in Pharmacological Science 7 (Suppl.): 56–60, 1986

    Google Scholar 

  • Palacios JM, Wamsley JK, Kuhar MJ. The distribution of histamine H1 receptors in the rat brain: an autoradiographic study. Neuroscience 6: 15–38, 1981

    CAS  PubMed  Google Scholar 

  • Palazzo MGA, Strunin L. Anaesthesia and emesis. I. Etiology. Canadian Anaesthesia Society Journal 31: 178–187, 1984a

    CAS  Google Scholar 

  • Palazzo MGA, Strunin L. Anaesthesia and emesis II: prevention and management. Canadian Anaesthesia Society Journal 31: 407–415, 1984b

    CAS  Google Scholar 

  • Parkes JD. A neurologist’s view of nausea and vomiting. In Davis CJ, et al. (Eds) Nausea and vomiting: mechanisms and treatment pp. 160–166, Springer, Berlin, 1986

    Google Scholar 

  • Parkes JD. Domperidone and Parkinson’s disease. In Calne DB (Ed) Handbook of experimental pharmacology, Vol. 88, Drugs for the treatment of Parkinson’s disease, pp. 515–530, Springer, Berlin, 1989

    Google Scholar 

  • Parnes SM, Spektor Z, Strominger N. Effects of lidocaine infusion in cats after unilateral labyrinthectomy. Archives of Otolaryngology — Head and Neck Surgery 114: 653–656, 1988

    CAS  PubMed  Google Scholar 

  • Pausescu E, Chirvasie R, Teodosiu T, Paun C. Effects of 60Co γ-radiation on the hepatic and cerebral levels of some prostaglandins. Radiation Research 65: 163–171, 1976

    CAS  PubMed  Google Scholar 

  • Peatfield R. Drugs and the treatment of migraine. Trends in Pharmacological Science 9: 141–145, 1988

    CAS  Google Scholar 

  • Pedigo Jr NW, Brizzee KR. Muscarinic cholinergic receptors in area postrema and brainstem areas regulating emesis. Brain Research Bulletin 14: 169–177, 1985

    CAS  PubMed  Google Scholar 

  • Pepperell RJ. Antinauseants in pregnancy. Australian Prescriber 8: 63–64, 1985

    Google Scholar 

  • Peroutka SJ. Combination antiemetics. Cancer Treatment Reports 66: 1449, 1982

    CAS  PubMed  Google Scholar 

  • Peroutka SJ. 5-Hydroxytryptamine receptor subtypes. Annual Review of Neuroscience 11: 45–60, 1988a

    CAS  PubMed  Google Scholar 

  • Peroutka SJ. 5-Hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization. Trends in Neuroscience 11: 496–500, 1988b

    CAS  Google Scholar 

  • Peroutka SJ. 5-Hydroxytryptamine receptor subtypes. Pharmacology and Toxicology 67: 373–383, 1990

    CAS  PubMed  Google Scholar 

  • Peroutka SJ, Snyder SH. Antiemetics: neurotransmitter receptor binding predicts therapeutic actions. Lancet 1: 658–659, 1982

    CAS  PubMed  Google Scholar 

  • Peters JA, Lambert JJ. Electrophysiology of 5-HT3 receptors in neuronal cell lines. Trends in Pharmacological Sciences 10: 172–175, 1989

    CAS  PubMed  Google Scholar 

  • Pickel VM, Armstrong DM. Ultrastructural localization of monoamines and peptides in rat area postrema. Federation Proceedings 43: 2949–2951, 1984

    CAS  PubMed  Google Scholar 

  • Pinder RM, Brogden RN, Sawyer PR, Speight TM, Avery GS. Metoclopramide: a review of its pharmacological properties and clinical use. Drugs 12: 81–131, 1976

    CAS  PubMed  Google Scholar 

  • Pinkerton CR, Williams D, Wootton C, Meller ST, McElwain TJ. 5-HT3 antagonist ondansetron: an effective outpatient antiemetic in cancer treatment. Archives of Disease in Childhood 65: 822–825, 1990

    CAS  PubMed  Google Scholar 

  • Plezia PM, Alberts DS. Nausea and vomiting: mechanisms and management. Clinics in Oncology (Eastbourne) 4: 357–386, 1985

    Google Scholar 

  • Plosker GL, Goa KL. Granisetron: a review of its pharmacological properties and therapeutic use as an antiemetic. Drugs 42(5): 805–824, 1991

    CAS  PubMed  Google Scholar 

  • Pratt GD, Bowery NG. The 5-HT3 receptor ligand [3H]BRL 43694 binds to presynaptic sites in the nucleus tractus solitarius of the rat. Neuropharmacology 28: 1367–1376, 1989

    CAS  PubMed  Google Scholar 

  • Price NM, Schmitt LG, McGuire J, Shaw JE, Trobough G. Trans-dermal scopolamine in the prevention of motion sickness at sea. Clinical Pharmacology and Therapeutics 29: 414–419, 1981

    CAS  PubMed  Google Scholar 

  • Priestman TJ. Clinical studies with ondansetron in the control of radiation-induced emesis. European Journal of Cancer and Clinical Oncology 25 (Suppl.1): S29–S33, 1989

    Google Scholar 

  • Proctor JD, Chremos AN, Evans EF, Wasserman AJ. An apomorphine-induced vomiting model for antiemetic studies in man. Journal of Clinical Pharmacology 18: 95–99, 1978

    CAS  PubMed  Google Scholar 

  • Purkis IE. Factors that influence postoperative vomiting. Canadian Anaesthesia Society Journal 11: 335–353, 1964

    CAS  Google Scholar 

  • Rall TW. The methylxanthines. In Goodman LS, et al. (Eds) The pharmacological basis of therapeutics 7th ed., pp. 589–603, MacMillan, New York, 1985

    Google Scholar 

  • Rich MW, Abdulhayoglu G, DiSaia PJ. Methylprednisolone as an antiemetic drug during cancer chemotherapy: a pilot study. Gynecologic Oncology 9: 193–198, 1980

    CAS  PubMed  Google Scholar 

  • Richards JG, Schoch P, Mönier H, Haefely W. Benzodiazepine receptors resolved. Experientia 42: 121–125, 1986

    CAS  PubMed  Google Scholar 

  • Richardson BP, Engel G. The pharmacology and function of 5-HT3 receptors. Trends in Neurosciences 9: 424–428, 1986

    CAS  Google Scholar 

  • Riding JE. Post-operative vomiting. Proceedings of the Royal Society of Medicine 53: 671–675, 1960

    CAS  PubMed  Google Scholar 

  • Riding JE. Minor complications of general anaesthesia. British Journal of Anaesthesia 47: 91–101, 1975

    CAS  PubMed  Google Scholar 

  • Rita L, Goodazzi M, Seleny F. Effect of low dose droperidol on postoperative vomiting in children. Canadian Anaesthesia Society Journal 28: 259–262, 1981

    CAS  Google Scholar 

  • Robinson, OPW. Metoclopramide: side effects and safety. Postgraduate Medical Journal 49 (Suppl.4): 77–80, 1973

    PubMed  Google Scholar 

  • Ross-Lee LM, Eadie MJ, Heazlewood V, Bochner F, Tyrer JH. Aspirin pharmacokinetics in migraine: the effect of metoclopramide. European Journal of Clinical Pharmacology 24: 777–785, 1983

    CAS  PubMed  Google Scholar 

  • Rotrosen J, Wallach MB, Angrist B, Gershon S. Antagonism of apomorphine-induced stereotypy and emesis in dogs by thioridazine, haloperidol and pimozide. Psychopharmacologia 26: 185–194, 1972

    CAS  PubMed  Google Scholar 

  • Roussak JB, Carey P, Parry H. Cardiac arrest after treatment with intravenous domperidone. British Medical Journal 289: 1579, 1984

    CAS  PubMed  Google Scholar 

  • Rowe JW, Shelton RL, Helderman JH, Vestal RE, Robertson GL. Influence of emetic reflex on vasopressin release in man. Kidney International 16: 729–735, 1979

    CAS  PubMed  Google Scholar 

  • Sadusk Jr JF, Palmisano PA. Teratogenic effect of meclizine, cyclizine and chlorcyclizine. Journal of the American Medical Association 194: 987–989, 1965

    PubMed  Google Scholar 

  • Sallan SE, Cronin C, Zelen M, Zinberg NE. Antiemetics in patients receiving chemotherapy for cancer. New England Journal of Medicine 302: 135–138, 1980

    CAS  PubMed  Google Scholar 

  • Sancilio LF, Pinkus LM, Jackson CB, Munson Jr HR. Studies on the emetic and antiemetic properties of zacopride and its enantiomers. European Journal of Pharmacology 192: 365–369, 1991

    CAS  PubMed  Google Scholar 

  • Sanger GJ. Effects of metoclopramide and domperidone on cholinergically mediated contractions of human isolated stomach muscle. Journal of Pharmacy and Pharmacology 37: 661–664, 1985

    CAS  PubMed  Google Scholar 

  • Sanger GJ. New antiemetic drugs. Canadian Journal of Physiology and Pharmacology 68: 314–324, 1990

    CAS  PubMed  Google Scholar 

  • Sanger GJ, Nelson DR. Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron). European Journal of Pharmacology 159: 113–124, 1989

    CAS  PubMed  Google Scholar 

  • Saxena PR, Ferrari MD. 5-HT1-like receptor agonists and the pathophysiology of migraine. Trends in Pharmacological Sciences 10: 200–204, 1989

    CAS  PubMed  Google Scholar 

  • Schachter M, Bédard P, Debono AG, Jenner P, Marsden CD, et al. The role of D1 and D2 receptors. Nature 286: 157–159, 1980

    CAS  PubMed  Google Scholar 

  • Schaffar N, Kessler JP, Bosler O, Jean A. Central serotonergic projections to the nucleus tractus solitarii: evidence from a double labeling study in the rat. Neuroscience 26: 951–958, 1988

    CAS  PubMed  Google Scholar 

  • Schmoll HJ. The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing chemotherapy regimens. European Journal of Cancer and Clinical Oncology 25 (Suppl.1): S35–S39, 1989

    Google Scholar 

  • Schwartz J-C, Agid Y, Bouthenet M-L, Jayoy-Agid F, Llorens-Cortes C, et al. Neurochemical investigations into the human area postrema. In Davis CJ, et al. (Eds) Nausea and vomiting: mechanisms and treatment pp. 18–30, Springer, Berlin, 1986

    Google Scholar 

  • Schwörer H, Racké K. Effects of cisplatin (CP) on the release of 5-hydroxytryptamine (5-HT) from guinea pig small intestine: involvement of 5-HT3 receptors. Naunyn-Schmiedebergs Archives of Pharmacology 339: R96, 1989

    Google Scholar 

  • Shaughnessy AF. Potential uses for metoclopramide. Drug Intelligence and Clinical Pharmacy 19: 723–728, 1985

    CAS  PubMed  Google Scholar 

  • Sheffield LJ, Bagatol R. The creation of therapeutic orphans — or, what have we learnt from the Debendox fiasco? Medical Journal of Australia 143: 143–147, 1985

    CAS  PubMed  Google Scholar 

  • Shorvon LM. Pyridoxine in treatment of radiation sickness. British Journal of Radiology 19: 369–370, 1946

    CAS  PubMed  Google Scholar 

  • Shorvon LM. A further survey of radiation sickness with particular reference to its treatment by pyridoxine. British Journal of Radiology 22: 49–55, 1949

    CAS  PubMed  Google Scholar 

  • Sibley DR. Cloning of a ‘D3’ receptor subtype expands dopamine receptor family. Trends in Pharmacological Sciences 12: 7–9, 1991

    CAS  PubMed  Google Scholar 

  • Silverman A, Kligerman MM, Fertig JW, Ellis K. A study of the effectiveness of pyridoxine and dramamine on clinical radiation sickness. Radiology 66: 403–407, 1956

    CAS  PubMed  Google Scholar 

  • Smith DB, Newlands ES, Rustin GJS, Begent RHJ, Crawford SM, et al. A phase I/II study of the 5-HT3 antagonist GR 38032F in the anti-emetic prophylaxis of patients receiving high-dose cisplatin chemotherapy. Cancer Chemotherapy Pharmacology 25: 291–294, 1990

    CAS  Google Scholar 

  • Smith DB, Newlands ES, Rustin GJS, Begent RHJ, Howells N, et al. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 338: 487–490, 1991

    CAS  PubMed  Google Scholar 

  • Smith RN. Safety of ondansetron. European Journal of Clinical Oncology (Suppl.1): S47–S50, 1989

    Google Scholar 

  • Smith WL, Alphin RS, Jackson CB, Sancilio LF. The antiemetic profile of zacopride. Journal of Pharmacy and Pharmacology 105, 1989

    Google Scholar 

  • Snyder SH. Planning for serendipity. Nature 346: 508, 1990

    CAS  PubMed  Google Scholar 

  • Sokoloff P, Giros B, Martres MP, Routhenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347: 146–151, 1990

    CAS  PubMed  Google Scholar 

  • Soules MR, Hughes Jr CL, Garcia JA, Livengood CH, Prystowsky MR, et al. Nausea and vomiting of pregnancy: role of human chorionic gonadotrophin and 17-hydroxyprogesterone. Obstetrics and Gynaecology 55: 696–700, 1980

    CAS  Google Scholar 

  • Spelina KR, Gerber HR, Pagels IL. Nausea and vomiting during spinal anaesthesia. Anaesthesia 39: 132–137, 1984

    CAS  PubMed  Google Scholar 

  • Steel LK, Sweedler IK, Catravas GN. Effects of 60Co radiation on synthesis of prostaglandins F2α, E and thromboxane B2 in lung airways of guinea pigs. Radiation Research 94: 156–165, 1983

    CAS  PubMed  Google Scholar 

  • Stern RM, Koch KL, Stewart WR, Lindblad IM. Spectral analysis of tachygastria recorded during motion sickness. Gastroenterology 92: 92–97, 1987

    CAS  PubMed  Google Scholar 

  • Stern Y, Sano M, Mayeux R. Long-term administration of oral physostigmine in Alzheimer’s disease. Neurology 38: 1837–1841, 1988

    CAS  PubMed  Google Scholar 

  • Stewart DJ. Cancer therapy, vomiting, and antiemetics. Canadian Journal of Physiology and Pharmacology 68: 304–313, 1990

    CAS  PubMed  Google Scholar 

  • Stewart IA, Maran AGD. The effects of metoclopramide on nystagmus and vertigo. Postgraduate Medical Journal 49 (Suppl.4) 19–21, 1973

    CAS  PubMed  Google Scholar 

  • Stewart JJ, Wood MJ, Wood CD, Mims ME. Effects of ginger on motion sickness susceptibilty and gastric function. Pharmacology 42: 111–120, 1991

    CAS  PubMed  Google Scholar 

  • Stoll BA. Radiation sickness: an analysis of over 1,000 controlled drug trials. British Medical Journal 2: 507–510, 1962

    CAS  PubMed  Google Scholar 

  • Stott JRR, Barnes GR, Wright RJ, Ruddock CJS. The effect on motion sickness and oculomotor function of GR 38032F, a 5-HT3-receptor antagonist with anti-emetic properties. British Journal of Clinical Pharmacology 27: 147–157, 1989

    CAS  PubMed  Google Scholar 

  • Strange PG. Aspects of the structure of the D2 dopamine receptor. Trends in Neurosciences 13: 373–378, 1990

    CAS  PubMed  Google Scholar 

  • Stryker JA, Demers LM, Mortel R. Prophylactic ibuprofen administration during pelvic irradiation. International Journal of Radiation Oncology Biology Physics 5: 2049–2052, 1979

    CAS  Google Scholar 

  • Sunderland T, Tarrot PN, Newhouse PA. Differential responsivity of mood, behaviour and cognition to cholinergic agents in elderly neuropsychiatric populations. Brain Research Review 13: 371–389, 1988

    Google Scholar 

  • Swann IL, Thompson EN, Qureshi K. Domperidone or metoclopramide in preventing chemotherapeutically induced nausea and vomiting. British Medical Journal 2: 1188, 1979

    CAS  PubMed  Google Scholar 

  • Tarsy D, Parkes JD, Marsden CD, et al. Metoclopramide and pimozide in Parkinson’s disease and levodopa induced dyskinesias. Journal of Neurology, Neurosurgery and Psychiatry 38: 331–335, 1975

    CAS  Google Scholar 

  • Taylor WB, Bateman DN. Antiemetics and cytotoxic drugs. British Medical Journal 287: 841, 1983

    Google Scholar 

  • Tebrock HE, Fisher MM. Nausea and vomiting evaluation of an orally administered phosphorated carbohydrate solution. Medical Times 82: 271–275, 1954

    CAS  PubMed  Google Scholar 

  • Tfelt-Hansen P, Olesen J, Aebelholt-Krabbe A, Melgaard B, et al. A double blind study of metoclopramide in the treatment of migraine attacks. Journal of Neurology, Neurosurgery and Psychiatry 43: 369–371, 1980

    CAS  Google Scholar 

  • Thoman ME, Verhulst HL. Ipecac syrup in antiemetic ingestion. Journal of the American Medical Association 196: 433–434, 1966

    CAS  PubMed  Google Scholar 

  • Thomas J. Prescription Products Guide, 17th ed., Australian Pharmaceutical Publishing Company, Hawthorn, 1988

    Google Scholar 

  • Thornton WE, Moore TP, Pool SL, Vanderploeg J. Clinical characterization and etiology of space motion sickness. Aviation, Space and Environmental Medicine 58: A1–A8, 1987

    CAS  Google Scholar 

  • Tourtellotte WW, Reinglass JL. Newkirk TA. Cerebral dehydration action of glycerol. Clinical Pharmacology and Therapeutics 13: 159–171, 1972

    CAS  PubMed  Google Scholar 

  • Towse G. Cinnarizine — a labyrinthine sedative. Journal of Laryngology and Otology 94: 1009–1015, 1980

    CAS  PubMed  Google Scholar 

  • Triesman M. Motion sickness: an evolutionary hypothesis. Science 197: 493–495, 1977

    Google Scholar 

  • Triggle DJ. Structure activity relationships: chemical constitution and biological activity. In Triggle DJ, Triggle CR (Eds) Chemical pharmacology of the synapse pp. 233–430 Academic Press, London, 1976

    Google Scholar 

  • Triozzi PL, Laszlo J. Optimum management of nausea and vomiting in cancer chemotherapy. Drugs 34(1): 136–149, 1987

    CAS  PubMed  Google Scholar 

  • Trounce JR. Antiemetic and cytotoxic drugs. British Medical Journal 286: 327–329, 1983

    CAS  PubMed  Google Scholar 

  • Trumbull R, Chinn HI, Maag CH, Milch LJ, Handford SW, et al. Effect of certain drugs on the incidence of seasickness. Clinical Pharmacology and Therapeutics 1: 280–283, 1960

    CAS  PubMed  Google Scholar 

  • Tyers MB, Bunce KT, Humphrey PPA. Pharmacological and antiemetic properties of ondansetron. European Journal of Cancer and Clinical Oncology 25 (Suppl.1): S15–S19, 1989

    CAS  Google Scholar 

  • Tyler DB, Bard P. Motion sickness. Physiological Review 29: 311–369, 1949

    CAS  Google Scholar 

  • Uppington J, Dunnet J, Blogg CE. Transdermal hyoscine and postoperative nausea and vomiting. Anaesthesia 41: 16–20, 1986

    CAS  PubMed  Google Scholar 

  • Vale JA, Meredith TJ, Proudfoot AT. Syrup of ipecacuanha: is it really useful? British Medical Journal 293: 1321, 1986

    CAS  PubMed  Google Scholar 

  • Valenzuela JE, Dooley CP. Dopamine antagonists in the upper gastrointestinal tract. Scandinavian Journal of Gastroenterology 19 (Suppl. 96): 127–136, 1984

    CAS  Google Scholar 

  • Van den Berg AA, Lambourne A, Clyburn PA. The oculoemetic reflex. Anaesthesia 44: 110–117, 1989

    PubMed  Google Scholar 

  • Van den Berg AA, Lambourne A, Yazji NS, Laghari NA. Vomiting after ophthalmic surgery. Anaesthesia 42: 270–276, 1987

    PubMed  Google Scholar 

  • Van Nueten JM. Is dopamine an inhibitory modulator of gastric motility? Trends in Pharmacological Sciences 1: 233–235, 1980

    Google Scholar 

  • Van Nueten JM, Janssen PAJ. Comparative study of the effects of flunarizine and cinnarizine on smooth muscles and cardiac tissues. Archives Internationales de Pharmacodynamie et de Thérapie 204: 37–55, 1973

    PubMed  Google Scholar 

  • Vasquez TE, Evans DG, Ashburn WL. Efficacy of syrup of ipecac-induced emesis for emptying gastric contents. Clinical Nuclear Medicine 13: 638–639, 1988

    CAS  PubMed  Google Scholar 

  • Vincent BJ, McQuiston DJ, Einhorn LH, Nagy CM, Brames MJ. Review of cannabinoids and their antiemetic effectiveness. Drugs 25 (Suppl.1): 52–62, 1983

    PubMed  Google Scholar 

  • Viner CV, Selby PJ, Zulian GB, Gore ME, Butcher ME, et al. Ondansetron: a new safe and effective antiemetic in patients receiving high-dose melphalan. Cancer Chemotherapy Pharmacology 25: 449–453, 1990

    CAS  Google Scholar 

  • Volans GN. Migraine and drug absorption. Clinical Pharmacokinetics 3: 313–318, 1978

    CAS  PubMed  Google Scholar 

  • Waeber C, Dixon K, Hoyer D, Palacios JM. Localization by autoradiography of neuronal 5-HT3 receptors in the mouse CNS. European Journal of Pharmacology 151, 351–352, 1988

    CAS  PubMed  Google Scholar 

  • Wainscott G, Kaspi T, Volans GN. The influence of thiethylperazine on the absorption of effervescent aspirin in migraine. British Journal of Clinical Pharmacology 3: 1015–1021, 1976

    CAS  PubMed  Google Scholar 

  • Waldmann CS, Verghese C, Short SM, Goldhill DR, Evans SJW. The evaluation of domperidone and metoclopramide as antiemetics in day care abortion patients. British Journal of Clinical Pharmacology 19: 307–310, 1985

    CAS  PubMed  Google Scholar 

  • Wampler G. The pharmacology and clinical effectiveness of phenothiazines and related drugs for managing chemotherapy-induced emesis. Drugs 25 (Suppl.1): 35–51, 1983

    PubMed  Google Scholar 

  • Wamsley JK, Palacios JM. Histaminergic receptors. In Björklund A, Hökfelt T, Kuhar MJ (Eds) Handbook of chemical neuroanatomy. Vol. 3, Classical transmitters and transmitter receptors in the CNS, Part II, pp. 386–406, Elsevier, Amsterdam, 1984

    Google Scholar 

  • Wamsley JK, Lewis M, Young WS III, Kuhar MJ. Autoradiographic localization of muscarinic cholinergic receptors in rat brain stem. Journal of Neuroscience 1: 176–191, 1981

    CAS  PubMed  Google Scholar 

  • Wang SC. Emetic and antiemetic drugs. In Root WS, Hofmann FG (Eds) Physiological pharmacology II, pp. 255–328, Academic Press, New York, 1965

    Google Scholar 

  • Wang SC, Chinn HI. Experimental motion sickness in dogs: functional importance of chemoceptive emetic trigger zone. American Journal of Physiology 178: 111–116, 1954

    CAS  PubMed  Google Scholar 

  • Wang SC, Glaviano VV. Locus of emetic action of morphine and hydergine in dogs. Journal of Pharmacology and Experimental Therapeutics 3: 329–334, 1954

    Google Scholar 

  • Wang SC, Renzi AA, Chinn HI. Mechanism of emesis following x-irradiation. American Journal of Physiology 193: 335–339, 1958

    CAS  PubMed  Google Scholar 

  • Ward A, Holmes B. Nabilone: a preliminary review of its pharmacological properties and therapeutic use. Drugs 30: 127–144, 1985

    CAS  PubMed  Google Scholar 

  • Ward DJ. Fatal hypernatraemia after a saline emetic. British Medical Journal 2: 432, 1963

    CAS  PubMed  Google Scholar 

  • Warrington PS, Allan SG, Cornbleet MA, MacPherson JS, Smyth JF, et al. Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin. British Medical Journal 293: 1334–1337, 1986

    CAS  PubMed  Google Scholar 

  • Watling KJ. Radioligand binding studies identify 5HT3 recognition sites in neuroblastoma cell lines and mammalian CNS. Trends in Pharmacological Sciences 9: 227–229, 1988

    CAS  PubMed  Google Scholar 

  • Watt Jr RH, Keats AS. Prophylaxis and treatment of nausea and vomiting. Pharmacology for Physicians 2(12): 1–6, 1968

    Google Scholar 

  • Weddington Jr WW, Miller NJ, Sweet DL. Anticipatory nausea and vomiting associated with cancer chemotherapy. New England Journal of Medicine 307: 825–826, 1982

    PubMed  Google Scholar 

  • Weinstein BB, Mitchell GJ, Sustendal GF. Clinical experiences with pyridoxine hydrochloride in treatment of nausea and vomiting of pregnancy. American Journal of Obstetrics and Gynecology 46: 283–285, 1943

    Google Scholar 

  • Weinstein BB, Wohl Z, Mitchell GJ, Sustendal GF. Oral administration of pyridoxine hydrochloride in the treatment of nausea and vomiting of pregnancy. American Journal of Obstetrics and Gynecology 47: 389–394, 1944

    Google Scholar 

  • Whitehead VM. Cancer treatment needs better antiemetics. New England Journal of Medicine 293: 199–200, 1975

    CAS  PubMed  Google Scholar 

  • Wiholm B-E, Mortimer O, Boethius G, Häggström JE. Tardive dyskinesia associated with metoclopramide. British Medical Journal 288: 545–547, 1984

    CAS  PubMed  Google Scholar 

  • Willems JL, Lefebvre RA. Peripheral nervous pathways involved in nausea and vomiting. In Davis CJ, et al. (Eds) Nausea and vomiting: mechanisms and treatment pp. 56–64, Springer, Ber-lin, 1986

    Google Scholar 

  • Williams CJ, Davies C, Raval M, Middleton J, Luken J, et al. Comparison of starting antiemetic treatment 24 hours before or concurrently with cytotoxic chemotherapy. British Medical Journal 298: 430–431, 1989

    CAS  PubMed  Google Scholar 

  • Wilson DB, Dundee JW. Evaluation of the anti-emetic action of domperidone. Anaesthesia 34: 765–767, 1979

    CAS  PubMed  Google Scholar 

  • Winning TJ, Brock-Utne JG, Downing JW. Nausea and vomiting after anesthesia and minor surgery. Anesthesia and Analgesia 56: 674–677, 1977

    CAS  PubMed  Google Scholar 

  • Winter J, Hart LL. Transdermal scopolamine in nausea and vomiting. Drug Intelligence and Clinical Pharmacy 21: 712–713, 1987

    Google Scholar 

  • Wood CD, Graybiel A. A theory of motion sickness based on pharmacological reactions. Clinical Pharmacology and Therapeutics 11: 621–629, 1970

    CAS  PubMed  Google Scholar 

  • Wood CD, Manno JE, Wood MJ, Manno BR, Redetzki HM. Mechanisms of antimotion sickness drugs. Aviation Space and Environmental Medicine 58: A262–A265, 1987

    CAS  Google Scholar 

  • Wood CD, Stewart JJ, Wood MJ, Manno JE, Manno BR, et al. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness. Aviation Space and Environmental Medicine 61: 157–161, 1990

    CAS  Google Scholar 

  • Wright MR, Axelson JE, Rurak DW, McErlane B, McMorland GH, et al. Linearity of metoclopramide kinetics at doses of 5–20mg. British Journal of Clinical Pharmacology 26: 469–473, 1989

    Google Scholar 

  • Yerushalmy J, Milkovich L. Evaluation of the teratogenic effect of meclizine in man. American Journal of Obstetrics and Gynecology 93: 553–562, 1965

    CAS  PubMed  Google Scholar 

  • Ylikorkala O, Kauppila A, Haapalahti J. Follicle stimulating hormone, thyrotrophin, human growth hormone and prolactin in hyperemesis gravidarum. British Journal of Obstetrics and Gy-naecology 83: 528–533, 1976

    CAS  Google Scholar 

  • Young RW. Mechanism and treatment of radiation-induced nausea and vomitings In Davis CJ, et al. (Eds) Nausea and vomiting: mechanisms and treatment, pp. 94–109, Springer, Berlin, 1986

    Google Scholar 

  • Zezula J, Cortés R, Probst A, Palacios JM. Benzodiazepine receptor sites in the human brain: autoradiographic mapping. Neuroscience 25: 771–795, 1988

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Pharmacology, Victorian College of Pharmacy (Monash University), Parkville, Victoria, Australia

    F. Mitchelson

Authors
  1. F. Mitchelson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mitchelson, F. Pharmacological Agents Affecting Emesis. Drugs 43, 443–463 (1992). https://doi.org/10.2165/00003495-199243040-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199243040-00003

Keywords

Search

Navigation